Literature DB >> 22372773

The relationship of peripheral arterial disease and metabolic syndrome prevalence in asymptomatic US adults 40 years and older: results from the National Health and Nutrition Examination Survey (1999-2004).

Andrew D Sumner1, Yasser K Khalil, James F Reed.   

Abstract

Peripheral arterial disease (PAD) is a subclinical marker of coronary artery disease and identifies asymptomatic individuals at high risk for cardiovascular disease (CVD) events. The metabolic syndrome (MetS) is a constellation of clinical factors that increases the risk of developing diabetes and CVD. The authors' objectives were to estimate the prevalence of MetS in patients with PAD and to determine the prevalence of PAD in the population of asymptomatic US adults 40 years and older with MetS. The authors analyzed data from 3 National Health and Nutrition Examination Surveys (NHANES, 1999-2004). Prevalence of MetS as defined by the Third Report of the Adult Treatment Panel criteria and prevalence of associated cardiac risk factors were determined in 5376 asymptomatic participants 40 years and older. Presence of PAD was defined as ankle-brachial index <0.9. Estimates were weighted with the sample weights accounting for the unequal selection probability of complex NHANES sampling and over sampling of selected population subgroups. Prevalence of PAD in asymptomatic US adults 40 years and older was 4.2%. PAD prevalence in persons with MetS was 7.0% compared with 3.3% in persons without MetS. A total of 38% of the population with PAD also had MetS. High rates of abdominal obesity, hypertension, hyperglycemia, and low high-density lipoprotein cholesterol are significant contributors to both MetS and PAD. Persons with MetS have twice the risk of having PAD. Of persons with PAD, almost 40% have MetS. The presence of either PAD or MetS should warrant screening for both conditions so that risk stratification and management of risk factors may be performed.
© 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22372773      PMCID: PMC8108912          DOI: 10.1111/j.1751-7176.2011.00580.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  26 in total

1.  Metabolic syndrome in peripheral arterial disease: relationship with severity of peripheral circulatory insufficiency, inflammatory status, and cardiovascular comorbidity.

Authors:  Gregorio Brevetti; Vittorio Schiano; Giusy Sirico; Giuseppe Giugliano; Eugenio Laurenzano; Massimo Chiariello
Journal:  J Vasc Surg       Date:  2006-06-06       Impact factor: 4.268

Review 2.  The metabolic syndrome.

Authors:  Marc-Andre Cornier; Dana Dabelea; Teri L Hernandez; Rachel C Lindstrom; Amy J Steig; Nicole R Stob; Rachael E Van Pelt; Hong Wang; Robert H Eckel
Journal:  Endocr Rev       Date:  2008-10-29       Impact factor: 19.871

3.  Cardiovascular morbidity and mortality associated with the metabolic syndrome.

Authors:  B Isomaa; P Almgren; T Tuomi; B Forsén; K Lahti; M Nissén; M R Taskinen; L Groop
Journal:  Diabetes Care       Date:  2001-04       Impact factor: 19.112

4.  Low ankle-brachial pressure index predicts increased risk of cardiovascular disease independent of the metabolic syndrome and conventional cardiovascular risk factors in the Edinburgh Artery Study.

Authors:  Sarah H Wild; Christopher D Byrne; Felicity B Smith; Amanda J Lee; F Gerald R Fowkes
Journal:  Diabetes Care       Date:  2006-03       Impact factor: 19.112

5.  NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older.

Authors:  Charles M Alexander; Pamela B Landsman; Steven M Teutsch; Steven M Haffner
Journal:  Diabetes       Date:  2003-05       Impact factor: 9.461

6.  Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease.

Authors:  Curt Diehm; Jens Rainer Allenberg; David Pittrow; Matthias Mahn; Gerhart Tepohl; Roman L Haberl; Harald Darius; Ina Burghaus; Hans Joachim Trampisch
Journal:  Circulation       Date:  2009-11-09       Impact factor: 29.690

7.  Prevalence of metabolic syndrome in patients with clinically advanced peripheral vascular disease.

Authors:  Laila R Qadan; Adel A Ahmed; Hussein A Safar; Marzouk A Al-Bader; Amr A Ali
Journal:  Angiology       Date:  2008-04-02       Impact factor: 3.619

8.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.

Authors:  K G Alberti; P Z Zimmet
Journal:  Diabet Med       Date:  1998-07       Impact factor: 4.359

9.  Metabolic syndrome, inflammation, and risk of symptomatic peripheral artery disease in women: a prospective study.

Authors:  David Conen; Kathryn M Rexrode; Mark A Creager; Paul M Ridker; Aruna D Pradhan
Journal:  Circulation       Date:  2009-09-08       Impact factor: 29.690

10.  Prevalence of the metabolic syndrome in patients with coronary heart disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm.

Authors:  Petra M Gorter; Jobien K Olijhoek; Yolanda van der Graaf; Ale Algra; Ton J Rabelink; Frank L J Visseren
Journal:  Atherosclerosis       Date:  2004-04       Impact factor: 5.162

View more
  11 in total

Review 1.  Interethnic Differences in Serum Lipids and Implications for Cardiometabolic Disease Risk in African Ancestry Populations.

Authors:  Amy R Bentley; Charles N Rotimi
Journal:  Glob Heart       Date:  2017-05-17

2.  T-cadherin is essential for adiponectin-mediated revascularization.

Authors:  Jennifer L Parker-Duffen; Kazuto Nakamura; Marcy Silver; Ryosuke Kikuchi; Ulrich Tigges; Sumiko Yoshida; Martin S Denzel; Barbara Ranscht; Kenneth Walsh
Journal:  J Biol Chem       Date:  2013-07-03       Impact factor: 5.157

3.  Pravastatin stimulates angiogenesis in a murine hindlimb ischemia model: a positron emission tomography imaging study with (64)Cu-NOTA-TRC105.

Authors:  Hakan Orbay; Hao Hong; Jill M Koch; Hector F Valdovinos; Timothy A Hacker; Charles P Theuer; Todd E Barnhart; Weibo Cai
Journal:  Am J Transl Res       Date:  2013-12-01       Impact factor: 4.060

4.  Positron emission tomography imaging of angiogenesis in a murine hindlimb ischemia model with 64Cu-labeled TRC105.

Authors:  Hakan Orbay; Yin Zhang; Hao Hong; Timothy A Hacker; Hector F Valdovinos; James A Zagzebski; Charles P Theuer; Todd E Barnhart; Weibo Cai
Journal:  Mol Pharm       Date:  2013-06-17       Impact factor: 4.939

Review 5.  PET/SPECT imaging of hindlimb ischemia: focusing on angiogenesis and blood flow.

Authors:  Hakan Orbay; Hao Hong; Yin Zhang; Weibo Cai
Journal:  Angiogenesis       Date:  2012-11-02       Impact factor: 9.596

6.  [Pulmonary function in elderly subjects with metabolic syndrome and type II diabetes : Data from the Berlin Aging Study II].

Authors:  Nikolaus Buchmann; Kristina Norman; Elisabeth Steinhagen-Thiessen; Ilja Demuth; Rahel Eckardt
Journal:  Z Gerontol Geriatr       Date:  2015-10-27       Impact factor: 1.281

7.  Impact of weight loss on ankle-brachial index and interartery blood pressures.

Authors:  Mark A Espeland; Cora E Lewis; Judy Bahnson; William C Knowler; Judith G Regensteiner; Sarah A Gaussoin; Daniel Beavers; Karen C Johnson
Journal:  Obesity (Silver Spring)       Date:  2014-02-24       Impact factor: 5.002

8.  Serum nesfatin-1 is reduced in type 2 diabetes mellitus patients with peripheral arterial disease.

Authors:  Shimei Ding; Wei Qu; Shuangsuo Dang; Xuan Xie; Jing Xu; Yuhuan Wang; Aiyu Jing; Chunhong Zhang; Junhong Wang
Journal:  Med Sci Monit       Date:  2015-04-04

9.  Association of calcaneal quantitative ultrasound parameters with metabolic syndrome in middle-aged and elderly Chinese: a large population-based cross-sectional study.

Authors:  Min Sun; Mengdie Cao; Qi Fu; Zhenxin Zhu; Chuchen Meng; Jia Mao; Yun Shi; Yu Duan; Wei Tang; Xiaoping Huang; Wei He; Tao Yang
Journal:  BMC Endocr Disord       Date:  2014-02-14       Impact factor: 2.763

10.  Subclinical atherosclerosis, cardiovascular health, and disease risk: is there a case for the Cardiovascular Health Index in the primary prevention population?

Authors:  Sarah S Singh; Courtney S Pilkerton; Carl D Shrader; Stephanie J Frisbee
Journal:  BMC Public Health       Date:  2018-04-02       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.